Nationwide trial network Clinical Research Advantage operates a nationwide network of clinical trial sites with staff embedded in clinics, enabling rapid patient recruitment and broad geographic reach for Phase II to IV studies, presenting a sales angle around scalable enrollment capabilities.

Largest WH owned As the country’s largest wholly owned network of clinical trial sites, CRA can position itself as a stable, integrated partner with end-to-end site access, appealing to sponsors seeking consistency, control, and streamlined trial operations.

Experience 11k trials With a track record of completing over 11,000 clinical trials since founding and post-acquisitions, CRA demonstrates deep operational experience and credibility, supporting upsell opportunities in complex trials and long-term partnerships.

Diverse sponsor access CRA services pharmaceutical, biotech, medical device companies, and contract research organizations, enabling cross-market outreach to potential sponsors seeking diverse therapeutic areas and collaboration models via a single network.

Moderate revenue scale Current revenue range of 1–10 million with 501–1000 employees suggests room to upsell broader services, faster trial startup, and expanded investigator networks to mid-sized sponsors aiming for efficient scale without engaging top-tier CROs.